Effects of Azimilide on the Muscarinic Acetylcholine Receptor-Operated K+ Current and Experimental Atrial Fibrillation in Guinea-Pig Hearts

DOI Web Site 3 Citations 69 References
  • Nishida Atsushi
    Department of Pharmacology, Chiba University Graduate School of Medicine, Japan Discovery and Pharmacology Research Laboratories, Tanabe Seiyaku Co., Ltd., Japan
  • Reien Yoshie
    Department of Pharmacology, Chiba University Graduate School of Medicine, Japan
  • Ogura Takehiko
    Department of Pharmacology, Chiba University Graduate School of Medicine, Japan
  • Uemura Hiroko
    Department of Pharmacology, Chiba University Graduate School of Medicine, Japan
  • Tamagawa Masaji
    Department of Pharmacology, Chiba University Graduate School of Medicine, Japan
  • Yabana Hideo
    Discovery and Pharmacology Research Laboratories, Tanabe Seiyaku Co., Ltd., Japan
  • Nakaya Haruaki
    Department of Pharmacology, Chiba University Graduate School of Medicine, Japan

Search this article

Abstract

Effects of azimilide, a class III antiarrhythmic drug, on the acetylcholine (ACh) receptor-operated K+ current (IK.ACh) and the delayed rectifier K+ current (IK) were examined in guinea-pig atrial cells using patch-clamp techniques. Effects of azimilide on experimental atrial fibrillation (AF) were also examined in isolated guinea-pig hearts. In single atrial myocytes, azimilide inhibited both the rapid (IKr) and slow component of IK (IKs). Azimilide inhibited the IK.ACh induced by carbachol (CCh, 1 μM), adenosine (10 μM), and intracellular loading of GTPγS (100 μM) in a concentration-dependent manner. The IC50 values of azimilide for inhibiting the CCh-, adenosine-, and GTPγS-induced IK.ACh were 1.25, 29.1, and 20.9 μM, respectively, suggesting that azimilide inhibits IK.ACh mainly by blocking the muscarinic receptors. Azimilide concentration-dependently (0.3 – 10 μM) prolonged the action potential duration (APD) in the absence and presence of muscarinic stimulation. In isolated hearts, perfusion of CCh shortened the duration of the monophasic action potential (MAP) and effective refractory period (ERP) of the left atrium and lowered the atrial fibrillation threshold (AFT). Addition of azimilide inhibited the induction of AF by prolonging the duration of MAP and ERP. The IK.ACh inhibition by azimilide may at least in part contribute to the effectiveness to prevent parasympathetic-type AF.<br>

Journal

Citations (3)*help

See more

References(69)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top